Increasing Accessibility of Bayesian Network-Based Defined Approaches for Skin Sensitisation Potency Assessment
Authors:
- Tomaz MohoricTMTomaz Mohoric
- Anke WilmAWAnke Wilm
- Stefan OnkenSOStefan Onken
- Andrii MilovichAMAndrii Milovich
- Artem LogavochALArtem Logavoch
- Pascal AnkliPAPascal Ankli
- Ghada TagortiGTGhada Tagorti
- Johannes KirchmairJohannes Kirchmair
- Andreas SchepkyASAndreas Schepky
- Jochen KühnlJKJochen Kühnl
- Abdulkarim NajjarANAbdulkarim Najjar
- Barry HardyBHBarry Hardy
Open Access
Abstract
Skin sensitisation is a critical adverse effect assessed to ensure the safety of compounds and materials exposed to the skin. Alongside the development of new approach methodologies (NAMs), defined approaches (DAs) have been established to promote skin sensitisation potency assessment by adopting and integrating standardised in vitro, in chemico, and in silico methods with specified data analysis procedures to achieve reliable and reproducible predictions. The incorporation of additional NAMs could help increase accessibility and flexibility. Using superior algorithms may help improve the accuracy of hazard and potency assessment and build confidence in the results. Here, we introduce two new DA models, with the aim to build DAs on freely available software and the newly developed kDPRA for covalent binding of a chemical to skin peptides and proteins. The new DA models are built on an existing Bayesian network (BN) modelling approach and expand on it. The new DA models include kDPRA data as one of the in vitro parameters and utilise in silico inputs from open-source QSAR models. Both approaches perform at least on par with the existing BN DA and show 63% and 68% accuracy when predicting four LLNA potency classes, respectively. We demonstrate the value of the Bayesian network’s confidence indications for predictions, as they provide a measure for differentiating between highly accurate and reliable predictions (accuracies up to 87%) in contrast to low-reliability predictions associated with inaccurate predictions.Keywords
This publication has 24 references indexed in Scilit:
- Expansion of the Cosmetics Europe skin sensitisation database with new substances and PPRA dataRegulatory Toxicology and Pharmacology, 2022
- Skin Doctor CP: Conformal Prediction of the Skin Sensitization Potential of Small Organic MoleculesChemical Research in Toxicology, 2020
- Skin sensitization in silico protocolRegulatory Toxicology and Pharmacology, 2020
- Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 3. Apparent discrepancies between LLNA and GPMT sensitisation potential: False positives or differences in sensitivity?Regulatory Toxicology and Pharmacology, 2016
- Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative weight of evidence and adaptive testing strategyArchives of Toxicology, 2015
- Evaluation of combinations of in vitro sensitization test descriptors for the artificial neural network‐based risk assessment model of skin sensitizationJournal of Applied Toxicology, 2015
- Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practiceJournal of Applied Toxicology, 2013
- TIMES-SS—A promising tool for the assessment of skin sensitization hazard. A characterization with respect to the OECD validation principles for (Q)SARs and an external evaluation for predictivityRegulatory Toxicology and Pharmacology, 2007
- Local lymph node assay (LLNA) for detection of sensitization capacity of chemicalsMethods, 2007
- Development of an in vitro skin sensitization test using human cell lines: The human Cell Line Activation Test (h-CLAT)Toxicology in Vitro, 2006